$17.84
At close: Apr 30, 7:27 PM EDT
$17.99
0.150.84%
After Hours: 7:27 PM EDT
Comments
Loading...
Healthpeak Properties Analyst Ratings and Price Targets | NYSE:DOC | Benzinga
Healthpeak Properties Inc has a consensus price target of $20.75 based on the ratings of 21 analysts. The high is $28 issued by Deutsche Bank on October 21, 2024. The low is $14 issued by Truist Securities on December 22, 2023. The 3 most-recent analyst ratings were released by Argus Research, Baird, and Evercore ISI Group on April 29, 2025, April 29, 2025, and April 28, 2025, respectively. With an average price target of $22.67 between Argus Research, Baird, and Evercore ISI Group, there's an implied 26.00% upside for Healthpeak Properties Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Argus Research
Baird
Evercore ISI Group
Wedbush
Scotiabank
1calculated from analyst ratings
Analyst Ratings for Healthpeak Properties
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/29/2025 | Buy Now | 38.97% | Argus Research | John Staszak69% | $25 → $25 | Reiterates | Buy → Buy | Get Alert |
| 04/29/2025 | Buy Now | 22.29% | Baird | Amanda Sweitzer39% | $24 → $22 | Maintains | Outperform | Get Alert |
| 04/28/2025 | Buy Now | 16.73% | Evercore ISI Group | James Kammert33% | $23 → $21 | Maintains | Outperform | Get Alert |
| 04/28/2025 | Buy Now | 22.29% | Wedbush | Richard Anderson61% | $24 → $22 | Maintains | Outperform | Get Alert |
| 04/11/2025 | Buy Now | 33.41% | Wedbush | Richard Anderson61% | $24 → $24 | Reiterates | Outperform → Outperform | Get Alert |
| 02/28/2025 | Buy Now | 27.85% | Scotiabank | Nicholas Yulico53% | $24 → $23 | Maintains | Sector Outperform | Get Alert |
| 02/14/2025 | Buy Now | 33.41% | Wedbush | Richard Anderson61% | $24 → $27 | Maintains | Outperform | Get Alert |
| 02/11/2025 | Buy Now | 33.41% | Baird | Amanda Sweitzer39% | $25 → $24 | Maintains | Outperform | Get Alert |
| 12/10/2024 | Buy Now | 22.29% | Wells Fargo | Connor Siversky68% | $23 → $22 | Maintains | Equal-Weight | Get Alert |
| 12/05/2024 | Buy Now | 33.41% | Mizuho | Vikram Malhotra55% | $25 → $24 | Maintains | Outperform | Get Alert |
| 11/04/2024 | Buy Now | 44.52% | RBC Capital | Michael Carroll63% | $25 → $26 | Maintains | Outperform | Get Alert |
| 10/30/2024 | Buy Now | 38.97% | Baird | Amanda Sweitzer39% | $24 → $25 | Maintains | Outperform | Get Alert |
| 10/21/2024 | Buy Now | 55.64% | Deutsche Bank | Omotayo Okusanya63% | $20 → $28 | Upgrade | Hold → Buy | Get Alert |
| 10/01/2024 | Buy Now | 27.85% | Wells Fargo | Connor Siversky68% | $22 → $23 | Assumes | Equal-Weight → Equal-Weight | Get Alert |
| 09/16/2024 | Buy Now | 44.52% | Evercore ISI Group | James Kammert33% | $25 → $26 | Maintains | Outperform | Get Alert |
| 09/09/2024 | Buy Now | 33.41% | Scotiabank | Nicholas Yulico53% | $23 → $24 | Maintains | Sector Outperform | Get Alert |
| 08/28/2024 | Buy Now | 38.97% | Evercore ISI Group | James Kammert33% | $24 → $25 | Maintains | Outperform | Get Alert |
| 08/22/2024 | Buy Now | 22.29% | Citigroup | Michael Bilerman59% | $20 → $22 | Maintains | Neutral | Get Alert |
| 07/30/2024 | Buy Now | 38.97% | RBC Capital | Michael Carroll63% | $22 → $25 | Maintains | Outperform | Get Alert |
| 07/29/2024 | Buy Now | 38.97% | Wedbush | Richard Anderson61% | $22 → $25 | Maintains | Outperform | Get Alert |
| 05/16/2024 | Buy Now | 27.85% | Scotiabank | Nicholas Yulico53% | $22 → $23 | Maintains | Sector Outperform | Get Alert |
| 05/16/2024 | Buy Now | 16.73% | JP Morgan | Michael Mueller56% | $19 → $21 | Maintains | Neutral | Get Alert |
| 05/03/2024 | Buy Now | — | Wedbush | Richard Anderson61% | — | Upgrade | Neutral → Outperform | Get Alert |
| 04/22/2024 | Buy Now | 22.29% | Mizuho | Vikram Malhotra55% | → $22 | Reinstates | → Buy | Get Alert |
| 04/10/2024 | Buy Now | 22.29% | RBC Capital | Michael Carroll63% | $21 → $22 | Maintains | Outperform | Get Alert |
| 04/01/2024 | Buy Now | 38.97% | B of A Securities | Joshua Dennerlein50% | $18 → $25 | Upgrade | Underperform → Buy | Get Alert |
| 03/25/2024 | Buy Now | 5.61% | Wells Fargo | Connor Siversky68% | → $19 | Reinstates | → Equal-Weight | Get Alert |
| 03/08/2024 | Buy Now | 16.73% | RBC Capital | Michael Carroll63% | → $21 | Reinstates | → Outperform | Get Alert |
| 01/05/2024 | Buy Now | — | Keybanc | Todd Thomas59% | — | Downgrade | Overweight → Sector Weight | Get Alert |
| 01/02/2024 | Buy Now | 0.06% | Compass Point | Merrill Ross49% | $19 → $18 | Maintains | Buy | Get Alert |
| 12/22/2023 | Buy Now | -22.18% | Truist Securities | Michael Lewis69% | $15 → $14 | Maintains | Hold | Get Alert |
| 08/22/2023 | Buy Now | -22.18% | Citigroup | Michael Bilerman59% | $15 → $14 | Maintains | Neutral | Get Alert |
| 08/16/2023 | Buy Now | -16.62% | Truist Securities | Michael Lewis69% | → $15 | Reiterates | Hold → Hold | Get Alert |
| 08/07/2023 | Buy Now | -16.62% | Wells Fargo | Connor Siversky68% | $14 → $15 | Maintains | Underweight | Get Alert |
| 07/20/2023 | Buy Now | -19.4% | Morgan Stanley | Richard Hill56% | $14.5 → $14.5 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 05/26/2023 | Buy Now | -13.84% | JMP Securities | Aaron Hecht57% | → $15.5 | Initiates | → Market Outperform | Get Alert |
| 04/20/2023 | Buy Now | -22.18% | Wells Fargo | Connor Siversky68% | → $14 | Initiates | → Underweight | Get Alert |
| 04/19/2023 | Buy Now | -22.18% | Wells Fargo | Connor Siversky68% | → $14 | Initiates | → Underweight | Get Alert |
| 03/29/2023 | Buy Now | -16.62% | Credit Suisse | Omotayo Okusanya63% | → $15 | Reiterates | → Neutral | Get Alert |
| 03/27/2023 | Buy Now | 5.61% | Compass Point | Floris Van Dijkum58% | $21 → $19 | Maintains | Buy | Get Alert |
| 02/28/2023 | Buy Now | -16.62% | RBC Capital | Michael Carroll63% | $16 → $15 | Maintains | Sector Perform | Get Alert |
| 01/17/2023 | Buy Now | 0.06% | Barclays | Steve Valiquette54% | $20 → $18 | Maintains | Overweight | Get Alert |
| 12/14/2022 | Buy Now | -5.5% | Keybanc | Todd Thomas59% | → $17 | Upgrade | Sector Weight → Overweight | Get Alert |
| 11/01/2022 | Buy Now | -19.4% | Morgan Stanley | Richard Hill56% | $16.5 → $14.5 | Maintains | Equal-Weight | Get Alert |
| 10/28/2022 | Buy Now | -5.5% | JP Morgan | Michael Mueller56% | → $17 | Initiates | → Neutral | Get Alert |
| 08/31/2022 | Buy Now | -8.28% | Morgan Stanley | Richard Hill56% | $16 → $16.5 | Maintains | Equal-Weight | Get Alert |
| 07/15/2022 | Buy Now | -11.06% | Morgan Stanley | Richard Hill56% | $17.5 → $16 | Maintains | Equal-Weight | Get Alert |
| 07/11/2022 | Buy Now | -5.5% | Truist Securities | Michael Lewis69% | $18 → $17 | Maintains | Hold | Get Alert |
| 06/30/2022 | Buy Now | 11.17% | Jefferies | Jonathan Petersen60% | $21 → $20 | Maintains | Buy | Get Alert |
| 06/01/2022 | Buy Now | -2.72% | Morgan Stanley | Richard Hill56% | $18 → $17.5 | Maintains | Equal-Weight | Get Alert |
| 05/20/2022 | Buy Now | 5.61% | RBC Capital | Michael Carroll63% | $18 → $19 | Maintains | Sector Perform | Get Alert |
| 05/19/2022 | Buy Now | 0.06% | B of A Securities | Joshua Dennerlein50% | → $18 | Downgrade | Neutral → Underperform | Get Alert |
FAQ
What is the target price for Healthpeak Properties (DOC) stock?
The latest price target for Healthpeak Properties (NYSE:DOC) was reported by Argus Research on April 29, 2025. The analyst firm set a price target for $25.00 expecting DOC to rise to within 12 months (a possible 38.97% upside). 23 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Healthpeak Properties (DOC)?
The latest analyst rating for Healthpeak Properties (NYSE:DOC) was provided by Argus Research, and Healthpeak Properties reiterated their buy rating.
When was the last upgrade for Healthpeak Properties (DOC)?
The last upgrade for Healthpeak Properties Inc happened on October 21, 2024 when Deutsche Bank raised their price target to $28. Deutsche Bank previously had a hold for Healthpeak Properties Inc.
When was the last downgrade for Healthpeak Properties (DOC)?
The last downgrade for Healthpeak Properties Inc happened on January 5, 2024 when Keybanc changed their price target from N/A to N/A for Healthpeak Properties Inc.
When is the next analyst rating going to be posted or updated for Healthpeak Properties (DOC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Healthpeak Properties, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Healthpeak Properties was filed on April 29, 2025 so you should expect the next rating to be made available sometime around April 29, 2026.
Is the Analyst Rating Healthpeak Properties (DOC) correct?
While ratings are subjective and will change, the latest Healthpeak Properties (DOC) rating was a reiterated with a price target of $25.00 to $25.00. The current price Healthpeak Properties (DOC) is trading at is $17.99, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
